During the past decade, Orange Grove Family Practice conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orange Grove Family Practice" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Orange Grove Family Practice" are "Episodic Migraine" (2 trials), "Acute Migraine" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Migraine" (1 trials) and "Migraine Disorders" (1 trials). Many other conditions were trialed in "Orange Grove Family Practice" in a lesser frequency.

Most popular intervention types in "Orange Grove Family Practice" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Atogepant" (2 trials), "BFKB8488A" (1 trials), "Empagliflozin (oral)" (1 trials) and "Galcanezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Orange Grove Family Practice" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Orange Grove Family Practice". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Orange Grove Family Practice, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Orange Grove Family Practice, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".